Simultaneous quantification of tau and α-synuclein in cerebrospinal fluid by high-resolution mass spectrometry for differentiation of Lewy Body Dementia from Alzheimer's Disease and controls

The Analyst ◽  
2019 ◽  
Vol 144 (21) ◽  
pp. 6342-6351 ◽  
Author(s):  
Arthur Viodé ◽  
Stéphane Epelbaum ◽  
Imen Benyounes ◽  
Marc Verny ◽  
Bruno Dubois ◽  
...  
Keyword(s):  
Mass Spectrometry ◽  
Cerebrospinal Fluid ◽  
High Resolution ◽  
Lewy Body ◽  
High Resolution Mass Spectrometry ◽  
Lewy Body Dementia ◽  
Diagnostic Value ◽  
Simultaneous Quantification ◽  
Resolution Mass ◽  
Mass Spectrometry Assay

A novel mass spectrometry assay offers simultaneous quantification of CSF α-synuclein and tau and has potential diagnostic value.

Sign in / Sign up

Export Citation Format

Share Document